Latest News

The board of Genomma Lab Internacional, S.A.B. de C.V. ( BMV:LABB ) has announced that it will pay a dividend of...

If you are wondering what to do with PARK24 stock right now, you are not alone. The company has been on quite a ride recently, catching the attention of both cautious investors and growth seekers alike. In just the past week, PARK24’s share price has jumped 8.7%, an impressive move that adds to a 22.8% climb over the last year. Whether you are eyeing those numbers for the first time or you have been tracking PARK24 for years, it is hard to ignore this kind of momentum. Part of what is driving...

Earlier this month, Science Applications International Corporation (SAIC) lowered its fiscal 2026 revenue guidance to a range of US$7.25 billion to US$7.33 billion, signaling weaker organic revenue with projected declines of 5.5% and 4% for the third and fourth quarters, respectively. This cautious outlook comes despite a recent management reshuffle and ongoing share repurchases, highlighting the challenges SAIC faces in stabilizing its top-line growth amid a shifting government IT...

Earlier this month, Mid-America Apartment Communities presented at the BofA Securities 2025 Global Real Estate Conference in New York, where key executives detailed the company's focus on high-demand Sunbelt and southwestern markets, as well as their confidence in stable occupancy and growth prospects. An important insight emphasized by management was the expectation that continued migration trends and housing affordability challenges will support sustained apartment demand and position the...

Carnegie Mellon University and BNY Mellon recently announced a five-year, US$10 million partnership to launch the BNY AI Lab, which will drive artificial intelligence research, talent development, and industry collaboration with a dedicated facility on CMU’s Pittsburgh campus. This collaboration not only targets advanced AI solutions for financial services but also places BNY Mellon in a unique position to recruit top AI talent and shape the governance of emerging technologies in its...

If you have been watching the energy sector, you have probably noticed Valero Energy popping up on more investors’ radars lately. Maybe you are trying to decide if now is the moment to get in, take profits, or just keep riding along with the momentum. Let’s talk it through. Over the past year, Valero has jumped by 21.0%, and that is just a slice of the story. Over the last five years, the stock has ballooned a massive 301.6%. Even more striking, Valero has gained 14.6% in the past month alone...

Thinking about what to do with your Aker shares or considering getting in? You’re not alone, and it’s a smart question. Over the past few years, Aker has been on a journey that has turned more than a few heads. With a one-year gain of 38.3% and a 131.2% return over five years, the stock has delivered for investors who stuck with it. The year-to-date return of 22.3% signals that momentum has not let up, even as the rest of the market churns with uncertainty. While recent gains, such as the...

CRISPR Therapeutics AG recently presented encouraging clinical and commercial updates at major industry conferences in New York, featuring new data on its in vivo gene-editing pipeline and expanding adoption of its Casgevy therapy. The company’s progress across cardiovascular, oncology, and autoimmune programs highlights an ambition to extend its gene-editing technology beyond blood disorders. We’ll examine how the promising early CTX310 trial data shapes CRISPR Therapeutics’ investment...

Trying to figure out what to do with China Gas Holdings stock? You are not alone. After a solid year-to-date rally of 20.0%, it is no wonder investors are sizing up their next move. Over the past week, shares edged up by 2.1%. However, zoom out a little further and you will spot recent volatility. A 5.7% loss over the last month might make you hesitate, even though the stock is still up 40.1% over the past year. Taking an even wider view reveals a more sobering story, with the five-year...

If you have been eyeing Snap’s stock and wondering whether it finally deserves a spot in your portfolio, you are not alone. The ride has not been for the faint-hearted. After peaking a few years back, Snap’s price treaded downward, with a staggering 69.3% drop over five years and a 34.7% dip year-to-date. Even its one-year return sits at -23.9%, a reminder that long-term buy-and-hold investors have faced tough sledding. However, the story gets more interesting when you look at the recent...

Taiheiyo Cement (TSE:5233) might not be a household name on every investor's watchlist, but something about its recent price action has been drawing fresh attention. When a stock quietly posts a steady climb without a headline-grabbing event, it leaves investors wondering if they're witnessing the start of a meaningful revaluation or just riding short-term market optimism. For Taiheiyo Cement, the conversation seems to be shifting. Clearly, something about the company's fundamentals or...

Constellium (NYSE:CSTM) just made headlines with its announcement to extend a long-term partnership with Embraer, one of the heavyweights in global aviation. This deal will see Constellium continuing to supply high-performance aluminum solutions, including its advanced Airware alloy, across Embraer’s commercial, executive, and defense divisions. For investors, this agreement signals more than a continuity plan. It could be a sign that Constellium's products are increasingly indispensable to...

If you have Lithia Motors on your watchlist, you are probably wondering whether now is the right time to make a move. After all, the stock has proven it can deliver impressive gains, surging nearly 20% over the past year and climbing an eye-catching 54.7% across five years. But it is not all up and to the right. More recently, the shares are down a modest 1.6% in the last week, while bouncing back 11.0% over the past month. Year-to-date, the story is more mixed, with the stock down 4.2%. This...

ANI Pharmaceuticals (ANIP) has just turned heads with its latest announcement, projecting 2025 revenues in the range of $818 million to $843 million. That’s a jump of 33% to 37% over last year, a confident call from management that’s tough to ignore if you’re weighing your next move. This new guidance seems to have struck a chord with the market, and it’s no surprise; bold forecasts often get investors reassessing what the company might be worth. The positive momentum was already in motion...

In recent days, Inter Milan announced a significant leadership change with Cristian Chivu taking over as manager, alongside a strategic pivot toward recruiting younger players supported by enhanced financial stability under new ownership. This transition has not only signaled a long-term vision for talent development, but has also resulted in Inter surpassing Juventus in enterprise value amid ongoing efforts to strengthen its balance sheet and competitiveness in Serie A. We'll take a look...

If you have been eyeing AS ONE and wondering whether now is the right moment to make a move, you are definitely not alone. Investors are taking a closer look after noticing the stock's small but notable bounce lately. Over the last month, AS ONE’s price inched up by 2.5%, building on a 0.1% uptick over just the past week. The year-to-date gain sits at 1.4%, which suggests there may be a subtle shift in how the market sees the company’s prospects and risk profile. However, if we zoom out, the...

Trying to figure out what to do with SundrugLtd stock? You are far from alone. The past year has proven this company can go the distance, with the stock up 14.0% over the last twelve months and a healthy 13.9% gain year to date. Looking farther back, SundrugLtd delivered an impressive 39.7% total return over the last three years, keeping long-term holders substantially ahead of the market. However, short-term traders have faced a little turbulence recently, with the stock sliding 0.7% over...

In recent days, the Independent Development Trust (IDT) has come under renewed scrutiny following allegations of corruption involving suspended CEO Tebogo Malaka, including accusations of attempted bribery of a journalist and procurement irregularities linked to an R800 million oxygen plant project. This high-profile probe has triggered criticism of political interference and prompted the appointment of PwC to conduct an independent investigation, highlighting concerns around governance and...

Earlier this month, Honeywell International announced a US$600 million equity raise for its quantum computing subsidiary Quantinuum, valuing the business at US$10 billion pre-money, with funds aimed at advancing its next-generation Helio quantum computer and expanding global AI and scientific partnerships. This significant move highlights Honeywell’s deepening push into high-potential quantum and artificial intelligence markets, positioning Quantinuum for accelerated innovation and future...

If you are tracking Mesoblast (ASX:MSB), the company’s latest updates at major healthcare conferences in New York are tough to ignore. Mesoblast grabbed attention with news of a strong first quarter launch for Ryoncil, its FDA-approved therapy for pediatric steroid-refractory acute graft versus host disease (SR-aGvHD). In addition to highlighting early sales and new treatment sites coming online, management revealed plans to expand Ryoncil into additional indications, including adult SR-aGvHD...

Reddit recently reported strong quarterly results, marked by significant year-over-year revenue growth and its first-ever GAAP profitability, drawing notable attention from market participants. This period has also seen a surge in analyst optimism and institutional investor interest, even as concerns around valuation and sustainability remain prevalent. We'll explore how Reddit's first GAAP-profitable quarter and rapid revenue growth influence the company's long-term investment...

Thinking about what to do with Angang Steel stock? You are far from alone. With a share price that has more than doubled over the past year, up a striking 112.4%, investors have taken notice. The 3.7% rally in the last week may look small by comparison, but it hints at renewed momentum after a slightly softer month where the stock dipped 3%. Year-to-date, though, Angang Steel has surged 54.9%, handily outpacing broader indices and signaling there is something more at play than just luck or...

Thinking about what to do with Budweiser Brewing Company APAC stock? You are not alone. Investors have watched this iconic brewer’s shares swing wildly over the past few years, and the latest market action has left plenty of folks scratching their heads. In the last week, the stock slipped 3.6 percent, and over the last 30 days, it is down 4.6 percent. But step back to the start of the year and you will find a 12.0 percent gain, while the move over the past year is a solid 8.7 percent up. Of...

If you have been keeping an eye on JFE Holdings (TSE:5411), you may have noticed that the stock's recent performance is stirring up questions among investors about what is driving these movements and whether this could signal a shift in the company's outlook. With no dramatic headlines or sudden events rocking the boat, this quiet but steady activity is still worth a closer look. Sometimes, these subtle moves say as much about market sentiment as the headline-grabbing news we all...